ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 635591 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 635591; 2) Community: the network communities that were significantly associated with the response to NSC 635591; 3) Molecule: the relationships between components within communities and NSC 635591; 4) MDR: the compounds that were significantly associated with the NSC 635591.

NSC Compound Enrichment Correlation
NSC 625350 Benzenepropanoic acid, .beta.-(benzoylamino)-.alpha.- hydroxy-, (9,10-dihydro-9,10-dioxo-2-anthracenyl)methyl ester (R*,R*) 0.0366216145653013 -0.18019723
NSC 105023 RUBIFLAVIN 0.0392716453377535 0.72027776
NSC 163062 TRIPTOLIDE 0.0392716453377535 0.2727813
NSC 208734 ACLACINOMYCIN A 0.0392716453377535 0.65124683
NSC 237538 2,4-Thiazolidinedione, 5-(3-phenyl-2-propenylidene)- 0.0392716453377535 0.48450629
NSC 281613 Ethanol, 2,2'-[[4-[[[3-chloro-4-(2-phenyl-4-thiazolyl)phenyl]imino]methyl]-3-methylphenyl]imino]bis-, dimethanesulfonate (ester) 0.0392716453377535 0.46283197
NSC 3082 s-Triazine, 4,6-diamino-1-(m-bromophenyl)-1,2-dihydro-2,2-dimethyl-, hydrochloride (8CI) 0.0392716453377535 0.48159976
NSC 400938 Null 0.0392716453377535 0.22268526
NSC 529108 4-Fluoro-D,L-tryptophan 0.0392716453377535 0.3296853
NSC 610456 Camptothecin Derivative 0.0392716453377535 0.59460225
Total:130  Current:108    [First] [Prev] [Next] [Last]